// May 23, 2025
A path to locally manufactured quality medicines: Building capacity in Africa to conduct bioequivalence studies
The generic pharmaceutical industry in low- and middle-income countries sits at a significant cro
Dr. Amanda Lewin
Senior Technical Advisor, USP
Amanda Lewin, Ph.D. is a Senior Technical Advisor at US Pharmacopeia, where she leads the development and implementation of technical strategies that align with international standards for medical products regulation specifically related to bioequivalence studies. She provides high-quality technical assistance globally, advocates for the adoption of data standards, and delivers training on bioequivalence and clinical trials. Dr. Lewin has over six years of experience with the US FDA, specializing in oversight of bioequivalence and bioavailability studies, and holds a Ph.D. in Pharmacology from Georgetown University.